Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Advances in systemic sclerosis and related fibrotic and vascular conditions

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

Alisa E Koch* and Oliver Distler

Arthritis Research & Therapy 2007, 9(Suppl 2):S3 doi:10.1186/ar2187

Accesses  

  • Last 30 days: 43 accesses
  • Last 365 days: 542 accesses
  • All time: 4031 accesses

Cited by

BioMed Central: 7 citations

Proceedings   Open Access

Molecular targets for therapy in systemic sclerosis

Naoki Iwamoto, Oliver Distler Fibrogenesis & Tissue Repair 2012, 5(Suppl 1):S19 (6 June 2012)

Research article   Open Access Highly Accessed

Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

Gabor Erős, Saleh Ibrahim, Nikolai Siebert, Mihály Boros, Brigitte Vollmar Arthritis Research & Therapy 2009, 11:R43 (18 March 2009)

Review   Free Highly Accessed

Vascular involvement in rheumatic diseases: 'vascular rheumatology'

Zoltán Szekanecz, Alisa E Koch Arthritis Research & Therapy 2008, 10:224 (10 October 2008)

This article is part of a collection on The Scientific Basis of...

Editorial   Free

Association of ITGAV supports a role of angiogenesis in rheumatoid arthritis

Peter Ahnert, Holger Kirsten Arthritis Research & Therapy 2007, 9:108 (31 October 2007)

Review   Free

Genetic factors in systemic sclerosis

Maureen D Mayes, Maria Trojanowska Arthritis Research & Therapy 2007, 9(Suppl 2):S5 (15 August 2007)

Review   Free

How does endothelial cell injury start? The role of endothelin in systemic sclerosis

David Abraham, Oliver Distler Arthritis Research & Therapy 2007, 9(Suppl 2):S2 (15 August 2007)

Preface   Free

Systemic sclerosis and related connective tissue diseases: present and future

Lewis J Rubin, Carol M Black, Christopher P Denton, James R Seibold Arthritis Research & Therapy 2007, 9(Suppl 2):S1 (15 August 2007)